Severe Asthma (5)

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

Severe Asthma (5)

1) Which FEV1 threshold is used to define severe persistent asthma according to the National Asthma Education and Prevention Program (NAEPP)? *

1 point

a. ≤ 30% predicted

b. ≥ 60% predicted

c. ≤ 80% predicted

d. ≤ 60% predicted

2) According to the Global Initiative for Asthma (GINA) guidelines, control of severe asthma requires:
*

1 point

a. High-dose inhaled corticosteroids (ICS) alone

b. High-dose ICS/long-acting beta2-agonists (LABA)

c. As-needed reliever medication alone

d. Low-dose ICS/LABA

3) Which class of drugs might be considered as add-on therapy in patients with moderate to severe or severe eosinophilic phenotype asthma?
*

1 point

a. Monoclonal antibodies

b. Beta2 agonists

c. Mast cell stabilizers

d. Leukotriene modifiers

4) For patients with severe persistent asthma who continue to experience symptoms on a high-dose ICS plus LABA regimen, what do the NAEPP guidelines recommend that clinicians add to the regimen?
*

1 point

a. A short-acting beta-agonist (SABA) as needed for symptoms

b. Cromolyn

c. An oral corticosteroid

d. Theophylline

5) For patients with asthma who are severely symptomatic, which of the following tests should be performed?
*

1 point

a. Methacholine/histamine challenge

b. Allergen-inhalation challenge

c. ECG

d. MRI

Submit

Clear form

This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy

Forms